Featured Products View All

 
 

Product News View All

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease
Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease
Product News

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

READ MORE

Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab
Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab
Product News

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs.

READ MORE

Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells
Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells
Product News

Lonza has announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

READ MORE

QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold
QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold
Product News

The World Health Organization recommends IGRA tests in the First Edition of Essential In Vitro Diagnostics.

READ MORE

 
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy